Hepatitis C: The Basics

Published Online: Friday, February 24, 2012
Follow Pharmacy_Times:
Hepatitis C is a viral disease spread via blood that affects liver function and can lead to cirrhosis, cancer, and death. Risk factors include receiving blood transfusions or organ transplants before 1992, sharing intravenous drug needles or cocaine straws, engaging in rough sex, and receiving tattoos or piercings from unsterilized equipment. Unlike hepatitis A and B, there is no vaccine for hepatitis C. It can be cured through treatment, however, so it is important for those with risk factors to learn whether they have it.
 
Check out this video to learn more:

Related Articles
Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment.
A new study has revealed that many patients infected with the hepatitis C virus do not seek treatment and become lost in the different stages of health care to manage the disease.
The FDA today approved ombitasvir, paritaprevir, and ritonavir tablets copackaged with dasabuvir tablets to treat individuals with chronic hepatitis C virus genotype 1 infection, including patients with cirrhosis.
The Bristol-Myers Squibb Foundation today announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus and hepatitis C virus infection by focusing on the most vulnerable, high-risk patient populations.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$